140 related articles for article (PubMed ID: 15849811)
1. Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase.
Liang YC; Wu CH; Chu JS; Wang CK; Hung LF; Wang YJ; Ho YS; Chang JG; Lin SY
World J Gastroenterol; 2005 May; 11(17):2557-63. PubMed ID: 15849811
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma.
Sung YK; Hwang SY; Park MK; Bae HI; Kim WH; Kim JC; Kim M
Cancer Sci; 2003 May; 94(5):421-4. PubMed ID: 12824887
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells.
Sung YK; Park MK; Hong SH; Hwang SY; Kwack MH; Kim JC; Kim MK
Exp Mol Med; 2007 Aug; 39(4):477-82. PubMed ID: 17934335
[TBL] [Abstract][Full Text] [Related]
4. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
[TBL] [Abstract][Full Text] [Related]
5. The effect of fatty acid-CoA ligase 4 on the growth of hepatic cancer cells.
Hu C; Chen L; Jiang Y; Li Y; Wang S
Cancer Biol Ther; 2008 Jan; 7(1):131-4. PubMed ID: 18059177
[TBL] [Abstract][Full Text] [Related]
6. The role of cAMP-MAPK signalling in the regulation of human hepatocellular carcinoma growth in vitro.
Schmidt CM; McKillop IH; Cahill PA; Sitzmann JV
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1393-9. PubMed ID: 10654800
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.
Cao Y; Dave KB; Doan TP; Prescott SM
Cancer Res; 2001 Dec; 61(23):8429-34. PubMed ID: 11731423
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma.
Zhou Y; Wu PW; Yuan XW; Li J; Shi XL
Eur Rev Med Pharmacol Sci; 2016; 20(2):250-63. PubMed ID: 26875893
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling.
Zhang A; Lakshmanan J; Motameni A; Harbrecht BG
Mol Cell Biochem; 2018 Apr; 441(1-2):89-98. PubMed ID: 28887744
[TBL] [Abstract][Full Text] [Related]
10. Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways.
Lin Z; Li S; Guo P; Wang L; Zheng L; Yan Z; Chen X; Cheng Z; Yan H; Zheng C; Zhao C
Life Sci; 2019 Feb; 218():197-204. PubMed ID: 30582951
[TBL] [Abstract][Full Text] [Related]
11. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
12. miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway.
Yang F; Yin Y; Wang F; Wang Y; Zhang L; Tang Y; Sun S
Hepatology; 2010 May; 51(5):1614-23. PubMed ID: 20209605
[TBL] [Abstract][Full Text] [Related]
13. Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
Kang D; Han Z; Oh GH; Joo Y; Choi HJ; Song JJ
Yonsei Med J; 2017 Sep; 58(5):899-909. PubMed ID: 28792132
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma.
Iyoda K; Sasaki Y; Horimoto M; Toyama T; Yakushijin T; Sakakibara M; Takehara T; Fujimoto J; Hori M; Wands JR; Hayashi N
Cancer; 2003 Jun; 97(12):3017-26. PubMed ID: 12784337
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
Cheng Q; Cao X; Yuan F; Li G; Tong T
Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
[TBL] [Abstract][Full Text] [Related]
16. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
[TBL] [Abstract][Full Text] [Related]
17. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
19. Novel 1,4-naphthoquinone derivatives induce apoptosis via ROS-mediated p38/MAPK, Akt and STAT3 signaling in human hepatoma Hep3B cells.
Liu C; Shen GN; Luo YH; Piao XJ; Jiang XY; Meng LQ; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Li JQ; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Cui YD; Fang NZ; Jin CH
Int J Biochem Cell Biol; 2018 Mar; 96():9-19. PubMed ID: 29326072
[TBL] [Abstract][Full Text] [Related]
20. Expression of fatty acid-CoA ligase 4 during development and in brain.
Cao Y; Murphy KJ; McIntyre TM; Zimmerman GA; Prescott SM
FEBS Lett; 2000 Feb; 467(2-3):263-7. PubMed ID: 10675551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
